Variable | Number of index patients | Crude RR (95%CI) | Adjusted RR (95%CI) | |
---|---|---|---|---|
Age category (years) | 0–14 | 140 | 0.43 (0.30–0.62)* | 0.84 (0.56–1.26) |
15–24 | 486 | 1.60 (1.32–1.95)* | 0.94 (0.80–1.11) | |
25–44 | 890 | Referent | ||
45–64 | 378 | 0.77 (0.61–0.96)* | 1.02 (0.85–1.22) | |
65 and above | 417 | 0.93 (0.75–1.15) | 0.91 (0.77–1.09) | |
Sex | Female | 954 | Referent | |
Male | 1357 | 0.95 (0.81–1.10) | 0.93 (0.82–1.05) | |
Site of disease | Pulmonary | 1757 | Referent | |
Pulmonary plus additional sites | 555 | 0.51 (0.43–0.62)* | 0.58 (0.50–0.68)* | |
Patient detection pathway | Clinical Presentation | 1839 | Referent | |
Contact tracing | 131 | 0.132 (0.08–0.21)* | 0.29 (0.18–0.46)* | |
Screening | 24 | 0.49 (0.23–1.11) | 0.64 (0.33–1.22) | |
Health undertaking | 317 | 0.37 (0.29–0.46)* | 0.54 (0.44–0.67)* | |
CXR | Normal | 31 | Referent | |
Abnormal | 879 | 1.79 (0.84–3.60) | 1.18 (0.66–2.12) | |
Unknown | 1401 | 1.95 (0.91–3.91) | 1.27 (0.71–2.26) | |
Diagnosis | Culture | 1967 | Referent | |
PCR/NAT/Ht/Cs | 130 | 0.15 (0.09–0.23)* | 0.30 (0.19–0.45)* | |
Radiological | 214 | 0.21 (0.15–0.29)* | 0.45 (0.33–0.62)* | |
New or relapse | New case | 2177 | Referent | |
Relapse following full treatment | 83 | 1.23 (0.84–1.86) | 1.07 (0.78–1.47) | |
Relapse following partial treatment | 30 | 0.53 (0.26–1.14) | 0.70 (0.38–1.25) | |
Unknown | 21 | 1.38(0.67–3.24) | 1.02(0.56–1.91) | |
Number of contacts identified | 18019a | 1.06(1.05–1.06)* | 1.04(1.04–1.05)* |